0.31 (-14.95%)
As of Feb 22, 2023
Source:
Sorrento Therapeutics, Inc. (Nasdaq: SRNE), together with its subsidiaries is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical needs.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 858-203-4100 |
| Industry | manufacturing |
| CEO | Henry Ji |
| Website | www.sorrentotherapeutics.com |